Linking Omega-3 Fatty Acids and Depression
Abstract
Abstract Omega-3 polyunsaturated fatty acids (PUFAs) include α-linolenic acid (ALA), stearidonic acid (SDA), eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA), and docosahexaenoic acid (DHA). The major dietary sources of omega-3 PUFAs are oily fish, vegetable oils (i.e., soybean, canola, walnut, flaxseed), and seeds (i.e., chia, hemp, flaxseed). Several epidemiological studies demonstrated a significant inverse association between dietary intake of fish and depression, which is one of the leading causes of disability worldwide. However, studies conducted on the association between dietary omega-3 PUFAs intake and depression reported contrasting results, suggesting that the preventive role of omega-3 PUFAs toward depression may depend on other factors correlated with omega-3 PUFAs intake, such as adherence to a healthier dietary pattern and lifestyle factors. Accordingly, clinical evidence proposed that supplementation with omega-3 PUFAs may improve the symptomology in depressed patients, although definitive statements on their use in depression therapy cannot be yet asserted. Several molecular mechanisms were hypothesized to be implicated in the protective role of omega-3 PUFAs, including regulation of neuro-inflammation, modulation of adult hippocampal neurogenesis, neurite outgrowth, and synaptogenesis. Even though, scientific evidence supports the neuroprotective effects of omega-3 PUFAs, there are still some controversies about their efficacy. Therefore, further…
Read the paper
Related studies
- Promising Sources of Plant-Derived Polyunsaturated Fatty Acids: A Narrative Review
- Effects of omega-3 polyunsaturated fatty acid intake in patients with chronic kidney disease: Systematic review and meta-analysis of randomized controlled trials
- Effect of omega-3 fatty acids on cognition: an updated systematic review of randomized clinical trials
- The role of omega-3 polyunsaturated fatty acid supplementation in the management of type 2 diabetes mellitus: A narrative review
- Paucity of evidence for a relationship between long-chain omega-3 fatty acid intake and chronic obstructive pulmonary disease: a systematic review
- Omega-3 fatty acid nanocarriers: Characterization and potential applications
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.